Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.

A. Calin, R. M. Bennett, S. Sukhupunyaraksa, A. L. Goldman, H. E. Montoya, W. M. O'Brien, V. J. Giuliano, F. R. Schmid, R. F. Willkens, H. Y. Sakofsky

    Research output: Contribution to journalArticlepeer-review

    7 Scopus citations

    Abstract

    A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.

    Original languageEnglish (US)
    Pages (from-to)153-157
    Number of pages5
    JournalJournal of Rheumatology
    Volume4
    Issue number2
    StatePublished - Jun 1 1977

    ASJC Scopus subject areas

    • Rheumatology
    • Immunology and Allergy
    • Immunology

    Fingerprint Dive into the research topics of 'Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.'. Together they form a unique fingerprint.

    Cite this